FDA MedWatch: Fresenius Medical Care Recalls Sanxin Single Use Syringes for Leakages

FDA Medical Device Recall

Fresenius Medical Care Recalls Sanxin Single Use Syringes for Leakages

Do Not Use Certain Brands of Saline and Sterile Water Medical Products by Nurse Assist Because They May Not Be Sterile

FDA Safety Communication

FDA MedWatch: Fresenius Medical Care Recalls Some Hemodialysis Machines for Potential Exposure to Toxic Compounds

Fresenius Medical Care Recalls Some Hemodialysis Machines for Potential Exposure to Toxic Compounds

KCER Release Date: October 27, 2023

To: KCER Distribution list- including ESRD Network EDs and QIDs

FDA MedWatch: Exela Pharma Sciences, LLC Issues Voluntary Nationwide Recall of 8.4% Sodium Bicarbonate Injection, USP, 50 mEq/50 mL, Midazolam in 0.8% Sodium Chloride Injection 100 mg/100 mL, and ELCYS (cysteine hydrochloride Injection), USP 500 mg/10 mL

FDA MedWatch

 

FDA MedWatch: 4.2% Sodium Bicarbonate Injection, USP and 1% and 2% Lidocaine HCl Injection, USP by Hospira: Recall - Due to the Potential for Presence of Glass Particulate Matter

FDA MedWatch

 

FDA MedWatch: Novartis Issues Voluntary Nationwide Recall of One Lot of Sandimmune® Oral Solution (Cyclosporine Oral Solution, USP), 100 mg/mL Due to Crystallization

From KCER (Kidney Community Emergency Response) 

Fact Sheet related to ending of public health emergency

https://www.hhs.gov/about/news/2023/02/09/fact-sheet-covid-19-public-health-emergency-transition-roadmap.html 

FDA Safety Communication - Alcohol Antiseptic Recall

FDA MedWatch

 

Update: Potential Risk of Exposure to Toxic Compounds When Using Hemodialysis and Peritoneal Dialysis Systems – Letter to Health Care Providers

KCER Release Date: March 7, 2023

To: KCER Distribution list- including ESRD Network EDs and QIDs

Pages